MedTrace Logo

Ovarian Injection of PRP (Platelet -Rich Plasma) Vs Normal Saline in Premature Ovarian Insufficiency

NCT04922398 · Status: UNKNOWN · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2021-06-10

No results posted yet for this study

Summary

60 cases with premature ovarian insufficiency will be randomized to either receive PRP or saline injection in their ovaries. Then follow up by hormonal \& ultrasound \& clinically to monitor any changes

Conditions

  • Premature Ovarian Failure

Interventions

BIOLOGICAL

platelet rich plasma

blood will be withdrawn from the patient then separation of the platelet rich layer and then injection in the ovary

DRUG

Normal saline

0.9% normal saline will be injected in each ovary

Sponsors & Collaborators

  • Hawaa Fertility Center

    collaborator OTHER

  • Ahmed Saad

    lead OTHER

Principal Investigators

  • Mohamed F Elsherbiny, phd.MD · Professor of OB & GYN

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
42 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-06-20
Primary Completion
2021-12-01
Completion
2021-12-30

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04922398 on ClinicalTrials.gov